Trilostane NEW
| Price | $55 | $72 | $89 |
| Package | 25mg | 50mg | 100mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-28 |
Product Details
| Product Name: Trilostane | CAS No.: 13647-35-3 |
| Purity: 99.95% | Supply Ability: 10g |
| Release date: 2026/07/28 |
Product Introduction
Bioactivity
| Name | Trilostane |
| Description | Trilostane (Win 24540) is a synthetic androstane derivative with adrenocortical suppressive properties, reversibly inhibiting 3 beta-hydroxysteroid dehydrogenase delta [5-4] isomerase in the adrenal cortex. |
| In vitro | In MCF-7, Trilostane affects the transcription of genes involved in cell cycle regulation, cell adhesion and matrix formation. |
| In vivo | In MCF-7, Trilostane affects the transcription of genes involved in cell cycle regulation, cell adhesion and matrix formation. |
| Storage | Keep away from moisture,Keep away from direct sunlight,Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (30.36 mM), Solution. 10% DMSO+90% Saline : < 10 mg/mL (30.36 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. 10% DMSO+90% Corn Oil : 2 mg/mL (6.07 mM), Sonication is recommended. DMSO : 245 mg/mL (743.71 mM), Sonication is recommended. Ethanol : < 1 mg/mL (insoluble or slightly soluble) H2O : < 1 mg/mL (insoluble or slightly soluble) |
| Keywords | Win-24540 | Win24540 | Trilostane | Inhibitor | inhibit | 3 β-hydroxysteroid dehydrogenase |
| Inhibitors Related | Disulfiram | Mycophenolate Mofetil | Rotenone | Ribavirin | 18β-Glycyrrhetinic acid | Benzyl alcohol | 2-Methylaminoethanol | Methotrexate disodium | Dimethyl malonate | Isomalt | D-Mannitol | Ethyl potassium malonate |
| Related Compound Libraries | Failed Clinical Trials Compound Library | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | NO PAINS Compound Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-08-08 | ||
|
VIP6Y
|
Sinoway Industrial co., ltd.
|
2026-08-07 | ||
|
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2026-08-07 | ||
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-08-07 | ||
|
VIP3Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2026-08-07 | ||
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2026-08-05 | ||
| $1.00 |
VIP3Y
|
S&Y Biochem Co.,Ltd
|
2026-08-01 | |
|
VIP2Y
|
Xi an Biohorlden Industry Trade Co Ltd
|
2026-07-30 | ||
| $55.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-07-28 | |
| $2539.00 |
VIP6Y
|
Baoji Guokang Healthchem Co., Ltd.
|
2026-07-15 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY